View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Novo Nordisk Pharmatech Enters a Distribution Agreement with Signet Chemical Corporation

Novo Nordisk Pharmatech has entered an agreement with Signet Chemical Corporation for the distribution of its pharmaceutical range of quaternary ammonium compounds (FEF® Quats) to the healthcare industry in India, Bangladesh and Sri Lanka.

Managing director of Signet Harish Shah commented on this new collaboration: “We are pleased to be associated with Novo Nordisk Pharmatech which is the leading supplier of Quats to the pharmaceutical and biopharmaceutical markets. Novo Nordisk Pharmatech’s FeF® Quats complement our existing portfolio of excipients used especially for ophthalmic, nasal and topical dosage forms”.

Novo Nordisk Pharmatech manufactures Quats – benzalkonium chloride, cetrimide and cetyl trimethyl ammonium bromide (CTAB), including customised-grade in accordance with current good manufacturing practice (cGMP) ICH Q7 for active pharmaceutical ingredients, which is the highest available quality standard.

Its products comply with the latest pharmacopoeial standards and are extensively supported by Certificate of Suitability of Monographs of the European Pharmacopoeia (CEP), drug master files (DMF) and a comprehensive package of regulatory and quality assurance documents.

Novo Nordisk’s manufacturing site in Koege, Denmark, is audited by the Danish Medicines Agency and the US Food and Drug Administration (FDA).

Sales and marketing director at Novo Nordisk Pharmatech Steve Profit says: “We are very happy to work with Signet as our distribution partner for pharmaceuticals. Novo Nordisk Pharmatech’s FeF® Quats products fit perfectly with Signet’s wide range of excipients enabling the customers to take advantage of these synergies. We wish to give the best service to our customers and the local pharma team of Signet are experts in working with customers to support their product development”.

About Signet

Signet is one of India’s leading pharmaceutical excipient distributor companies offering a broad range of excipients. Founded in 1986, Signet Chemical Corporation combines technical expertise with commercial support to provide its clients accurate information and exceptional product value.

With 95 qualified and well-trained members, the Signet team has an excellent understanding of the intricacies of the market and has strong relationships with key partners to take the company forward. Signet has a turnover of approximately $174m with around 100 employees serving India, Bangladesh, Nepal and Sri Lanka.

For more than 30 years, the National Research Council of Canada has been helping clients develop, optimise, scale-up and transfer bioprocesses to produce biologics and...
The Chinese hamster ovary (CHO) cell line is widely used for the production of recombinant proteins due to its high growth capacity and productivity, as...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology